Singapore's Health Sciences Authority $(HSA)$ said on Monday it has granted an interim authorization for Novavax's COVID-19 vaccine.
The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.
Singapore's Health Sciences Authority $(HSA)$ said on Monday it has granted an interim authorization for Novavax's COVID-19 vaccine.
The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.
Comments